News – Page 375 – Endpoints News

Athenex discloses patient death, clinical hold on CAR-NKT trial as it seeks strategic alternatives

3 years ago

Gilead taps Nurix protein degrader option for $20M

3 years ago

Syneos Health inks deal with Microsoft to use AI technology

3 years ago

'No finding of research misconduct': MIT ends 3.5-year review of biotech founder, professor Sasisekharan

3 years ago

Daiichi and Zymeworks end antibody pact after seven years

3 years ago

Novartis and Biogen pull out of neuro drug partnerships with Sangamo

3 years ago

Karuna’s schizophrenia drug clears another PhIII as biotech seeks 2024 launch

3 years ago

What kind of PhIIb data is worth $4B cash? Takeda’s Andy Plump has some thoughts on that

3 years ago

Seagen goes to Pfizer for $43B; Sanofi buys diabetes partner Provention; Crisis averted in SVB demise; and more

3 years ago

J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest

3 years ago

Verastem's new campaign aims to make distinctions in rare type of ovarian cancer

3 years ago

GAO on combo product patents: Stakeholders split on need for Orange Book tweaks

3 years ago

Samsung Biologics to kick off $1.5B+ plant construction in South Korea

3 years ago

Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer

3 years ago

Ipsen receives new palovarotene PDUFA date; Acer halts development of ex-Sanofi drug

3 years ago

Pfizer's Bourla and Moderna's Bancel saw compensation bumps in 2022

3 years ago

Gossamer stops enrollment on BTK inhibitor program, goes all in on PAH drug

3 years ago

BeiGene decides not to license DKK1 drug, but keeps PD-1 combo trial in gastric cancer

3 years ago

Moderna's 'surprise' IP court order could set up a big settlement for Roivant, Arbutus — analysts

3 years ago

Pfizer, Astellas tout positive PhIII data to potentially expand Xtandi label

3 years ago

Ultragenyx adds new CMO with internal promotion; Autolus CFO to leave for MorphoSys — but not quite yet

3 years ago

In reversal, Sarepta to face FDA’s panel of outside experts on Duchenne gene therapy

3 years ago

Amgen cites inflation, pressure on drug prices in 450-person layoff

3 years ago

FDA adcomm votes in favor of Pfizer's Covid-19 pill Paxlovid

3 years ago

First page Previous page 372 373 374375376 377 378 Next page Last page